xma came earli buddi pump
still top pick chem asi mix cut benefit pt asi
post strong qtr despit weaker coat oral latter due
biz loss colgat pharmachem beat expect w/ msd growth
ebitda margin ex-corp ebitda investor focu
abil gener average growth pharma pc ex-or care
adhes drive mix benefit ii execut cost initi guid
like conserv iii sign sale composit marl biz
 ep go respect pt
goe see realist path given futur
asi independ post float rate debt reduct implement
cse buy-back despit construct manag rhetor
sens investor expect net proce composites/marl sale
resid risk raw materi divestitur time cost execut
pharma thesi leg global vaniti drive biofunct growth
loss colgat biz gantrez disappoint unavoid
possibl repurpos vol app dental cream etc time
execut count w/ pharma pois grow rang
 tailwind growth margin asian pharma emerg option
within pc haircar solid higher return biofunct drive
adhes perform well esp price investor overlook
pharmachem biz bear fruit via portfolio ration leverag
domest channel theme go global view
leav low bar asi cost cut front w/ cse margin
execut control price/cost integr asi bull thesi
maxim composites/marl net proce magnitud upsid
like roughli split cse proce debt-reduct
buy-back max credit spec chem world pro-forma valuat
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
ashland busi consist three segment ashland specialti
ingredi composit intermedi solvent
price rate outperform target price analyst christoph parkinson
profit tax
chang work capit
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
 close
scenario assum success sell
composit busi optim balanc sheet
remain busi ashland specialti ingredi purchas
ebitda discount back impli
grey scenario impli ebitda discount
back impli tp downsid base flat
asi organ growth continu raw materi pressur net price
slowdown composit demand result
longer lead time conclud sale lower multipl
compani mention price
